Docetaxel
6 FDA drug recalls involving brand “Docetaxel” — 2 Class I.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2024-05-28 | Class I | Docetaxel Injection, USP, 160 mg per 16 mL (10 mg per mL), 1 x 16 mL Multi-Dose Vial, Rx only, Mfd. for Sagent | Sagent Pharmaceuticals |
| 2024-05-28 | Class I | Docetaxel Injection, USP, 80 mg per 8 mL (10 mg per mL), 1 x 8 mL Multi-Dose Vial, Rx only, Mfd. for Sagent Ph | Sagent Pharmaceuticals |
| 2020-12-08 | Class II | Docetaxel Injection USP 160 mg/8mL (20 mg/mL), For Intravenous Infusion Only, Rx Only, 8 mL Single Use Vial, C | Shilpa Medicare Limited |
| 2019-03-06 | Class II | Docetaxel Injection USP, 80 mg/4 mL, (20 mg/mL), One-Vial Formulation, Rx only, Mfd By: Dr. Reddy's Laboratori | Dr. Reddy's Laboratories, Inc. |
| 2018-04-27 | Class II | Docetaxel injection concentrate, 20 mg/mL, 1 mL vial, Rx only, Winthrop U.S. a business of Sanofi-Aventis U.S. | Sanofi-Aventis U.S. LLC |
| 2017-01-09 | Class II | Docetaxel Injection USP, 20 mg/mL, One-Vial Formulation, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, V | Dr. Reddy's Laboratories, Inc. |